Profile of tear lipid mediator as a biomarker of inflammation for meibomian gland dysfunction and ocular surface diseases: Standard operating procedures-Reference-Cited by-同舟云学术

Profile of tear lipid mediator as a biomarker of inflammation for meibomian gland dysfunction and ocular surface diseases: Standard operating procedures

Published:2020-10 Issue: Volume: Page:
ISSN:1542-0124
Container-title:The Ocular Surface
language:en
Short-container-title:The Ocular Surface

Author:

Ambaw Yohannes Abere,Timbadia Dhayan Parresh,Raida Manfred,Torta Federico,Wenk Markus R.,Tong Louis

Funder

National Medical Research Council

Publisher

Elsevier BV

Subject

Ophthalmology

Reference37 articles.

1. Tear eicosanoids in healthy people and ocular surface disease;Ambaw;Sci Rep,2018

2. Changes of tear lipid mediators after eyelid warming or thermopulsation treatment for meibomian gland dysfunction;Ambaw;Prostag Other Lipid Mediat,2020

3. Change of tear lipid mediators in a post-trabeculectomy cohort;Ambaw;Ocul Surf,2020

4. The international workshop on meibomian gland dysfunction: executive summary;Nichols;Invest Ophthalmol Vis Sci,2011

5. Linoleic acid content of human meibum is associated with telangiectasia and plugging of gland orifices in meibomian gland dysfunction;Arita;Exp Eye Res,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Method Development for Omics Analyses using Schirmer Strips;Current Eye Research;2024-04-03

2. Tear biomarkers;Advances in Clinical Chemistry;2024

3. Production profile of lipid mediators in conjunctival lavage fluid in allergic and infectious conjunctivitis in guinea pigs;Frontiers in Allergy;2023-07-06

4. Lipidomics in Clinical Diagnostics;Mass Spectrometry for Lipidomics;2023-03-10

5. Genetic evidence implicating circulating lipids and lipid drug targets in pterygium;Computational and Structural Biotechnology Journal;2023